Review
Published on 10 Oct 2024
Bispecific antibody targets and therapies in multiple myeloma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1424925
- 3,850 views
Type at least 3 characters
7,225 articles
Articles
Original Research
Published on 10 Oct 2024
Pre-vaccination transcriptomic profiles of immune responders to the MUC1 peptide vaccine for colon cancer prevention
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1437391
- 1,678 views
Original Research
Published on 10 Oct 2024
Understanding bladder cancer risk: Mendelian randomization analysis of immune cell and inflammatory factor influence
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1460275
- 1,805 views
Review
Published on 10 Oct 2024
Revolutionizing the treatment for nasopharyngeal cancer: the impact, challenges and strategies of stem cell and genetically engineered cell therapies
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1484535
- 2,082 views
Original Research
Published on 10 Oct 2024
Modified Dendritic cell-based T-cell expansion protocol and single-cell multi-omics allow for the selection of the most expanded and in vitro-effective clonotype via profiling of thousands of MAGE-A3-specific T-cells
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1470130
- 1,895 views
Original Research
Published on 09 Oct 2024
Application of a risk score model based on glycosylation-related genes in the prognosis and treatment of patients with low-grade glioma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1467858
- 1,938 views
- 1 citation
Review
Published on 09 Oct 2024
Targeting STING signaling for the optimal cancer immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1482738
- 2,175 views
- 1 citation
Original Research
Published on 09 Oct 2024
Integrated analysis and experiments uncover the function of disulfidptosis in predicting immunotherapy effectiveness and delineating immune landscapes in uterine corpus endometrial carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1454730
- 1,617 views
Study Protocol
Published on 09 Oct 2024
SHR-8068 combined with adebrelimab and bevacizumab in the treatment of refractory advanced colorectal cancer: study protocol for a single-arm, phase Ib/II study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1450533
- 1,646 views
Original Research
Published on 09 Oct 2024
Global research trends and hotspots in metabolomics of osteosarcoma: a decade-spanning bibliometric and visualized analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1463078
- 1,357 views
Review
Published on 09 Oct 2024
Revealing the mechanism of natural product-induced immunogenic cell death: opening a new chapter in tumor immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1470071
- 1,342 views
Original Research
Published on 09 Oct 2024
Multi-omics analyses were combined to construct ubiquitination-related features in colon adenocarcinoma and identify ASNS as a novel biomarker
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1466286
- 1,639 views
Original Research
Published on 09 Oct 2024
Prognostic modeling of hepatocellular carcinoma based on T-cell proliferation regulators: a bioinformatics approach
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1444091
- 1,505 views
Original Research
Published on 08 Oct 2024
Association between statin use and immune-related adverse events in patients treated with immune checkpoint inhibitors: analysis of the FAERS database
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1439231
- 1,993 views
Editorial
Published on 08 Oct 2024
Editorial: Tumor microenvironment and metabolic reprogramming in cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1497966
- 888 views
Original Research
Published on 08 Oct 2024
Immune cell dynamics and the impact on the efficiency of transvascular antitumor interventional therapies in hepatocellular carcinoma patients
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2024.1450525
- 887 views